 |
|||||||||||||
MOST READ
|
|
Despite the Hype, Gilead’s Remdesivir Will Do Nothing to End the Coronavirus PandemicSharon LernerA combination of generic drugs appears to be more effective in fighting the coronavirus than Gilead Sciences’ remdesivir.
|
|
How the Fed Bailed Out the Investor Class Without Spending a CentDavid DayenJust announcing $4.5 trillion in future spending to support securities markets was enough to keep investors protected from the downsides of the pandemic.
|
Protecting freedom of the press has never been more important. Be the next person to support The Intercept's independent journalism by becoming a member today.Top Stories
|
|
ICE Detainee Who Died of Covid-19 Suffered Horrifying NeglectRyan DevereauxMen inside the Otay Mesa Detention Center, site of the largest coronavirus outbreak in ICE detention, say officials’ negligence lead to a man’s death.
|
|
Corporate Immunity, Mitch McConnell’s Priority for Coronavirus Relief, Is a Longtime Focus of the Conservative RightAkela LacyALEC, a Koch-backed group that drafts model bills for state legislators, has pushed corporate immunity measures on the state level since the early 2000s.
|
|
Coronavirus Monitoring Bracelets Flood the Market, Ready to Snitch on People Who Don’t DistanceSam BiddleA crop of “new” body-worn devices issue alerts about hospital patients, the quarantined, people under house arrest, and workers who fail to social distance.
|
|
At Debate, Progressive Jamaal Bowman Hits Israel Hawk Eliot Engel’s Defense Industry BackingAkela Lacy“He’s taken more money from weapons manufacturers than 144 Republicans in the House,” Bowman, Engel’s most serious challenger, said in a recent debate.
|
